Granzyme B inhibitor

The Granzyme B inhibitor is a chemical compound designed to selectively block the activity of Granzyme B, a serine protease released by cytotoxic T cells and natural killer cells during immune responses. Granzyme B plays a crucial role in cell-mediated cytotoxicity by inducing apoptosis in target cells through cleavage of various cellular substrates, including caspases and DNA repair proteins. The inhibitor functions by binding specifically to the active site of Granzyme B, thereby preventing its enzymatic activity and inhibiting the induction of apoptosis in target cells. In scientific research, the Granzyme B inhibitor has been instrumental in elucidating the mechanisms underlying cytotoxic T cell and natural killer cell-mediated killing of infected or cancerous cells. By blocking Granzyme B activity, researchers can investigate its role in immune surveillance and the clearance of aberrant cells. Moreover, the inhibitor has been employed in studies aiming to understand the regulation of Granzyme B expression and activation, as well as its contribution to immune evasion mechanisms employed by pathogens and tumors. Through its use in research, the Granzyme B inhibitor contributes to a deeper understanding of immune responses and their implications for human health and disease.